Home/Filings/4/0001593968-24-001367
4//SEC Filing

Draghia-Akli Ruxandra 4

Accession 0001593968-24-001367

CIK 0001000694other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:08 PM ET

Size

8.1 KB

Accession

0001593968-24-001367

Insider Transaction Report

Form 4
Period: 2024-11-11
Transactions
  • Award

    Restricted Stock Units

    2024-11-11+42,77042,770 total
    Exp: 2034-11-11Common Stock (42,770 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-11-11$9.01/sh+64,150$577,99264,150 total
    Exercise: $9.01From: 2025-11-11Exp: 2034-11-11Common Stock (64,150 underlying)
Footnotes (3)
  • [F1]Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
  • [F3]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1
  • filerCIK 0002041719

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:08 PM ET
Size
8.1 KB